Masako Asayama Selected Research

lenvatinib

1/2022

Updated Efficacy Outcomes of Anti-PD-1 Antibodies plus Multikinase Inhibitors for Patients with Advanced Gastric Cancer with or without Liver Metastases in Clinical Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masako Asayama Research Topics

Disease

7	Neoplasms (Cancer) 01/2020 - 08/2013
7	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 04/2011
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 08/2013
3	Disease Progression 08/2017 - 10/2008
2	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2018
2	Hemorrhage 01/2010 - 04/2008
1	Proteinuria 01/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2020
1	Exanthema (Rash) 01/2020
1	Ascites 04/2018
1	Fatigue 01/2018
1	Adenocarcinoma 10/2017
1	Thromboembolism 11/2015
1	Colic (Abdominal Cramps) 11/2015
1	Microsatellite Instability 12/2014
1	Insulinoma 02/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2014
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2014
1	Neuroendocrine Carcinoma 11/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2011
1	Ulcer 01/2010
1	Stomach Ulcer (Gastric Ulcer) 01/2010
1	Infarction (Infarctions) 10/2008
1	Polyarteritis Nodosa (Periarteritis Nodosa) 10/2008
1	Arteriovenous Malformations (Arteriovenous Malformation) 10/2008
1	Anemia 10/2008
1	Vasculitis (Vasculitides) 10/2008
1	Microaneurysm 10/2008
1	Enteritis 01/2007

Drug/Important Bio-Agent (IBA)

4	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 08/2013
3	regorafenibIBA 01/2022 - 01/2018
3	Capsules (Microcapsules)IBA 10/2008 - 01/2007
2	NivolumabIBA 01/2022 - 01/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 10/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 08/2017
2	Leucovorin (Folinic Acid)FDA Link 04/2018 - 10/2017
2	Trastuzumab (Herceptin)FDA Link 08/2017 - 08/2013
2	PlatinumIBA 08/2013 - 11/2011
1	lenvatinibIBA 01/2022
1	pembrolizumabIBA 01/2022
1	AntibodiesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	Cytotoxins (Cytolysins)IBA 08/2017
1	human ERBB2 proteinIBA 08/2017
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	Everolimus FDA Link 02/2014
1	Dihydrotachysterol (AT 10)IBA 02/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2014
1	Insulin (Novolin)FDA Link 02/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2013
1	ErbB Receptors (EGF Receptor)IBA 08/2013
1	afliberceptIBA 08/2013
1	amrubicinIBA 11/2011
1	Rabeprazole (Aciphex)FDA Link 01/2010
1	lafutidineIBA 01/2010
1	Therapeutic UsesIBA 01/2010
1	formycin diphosphate (FDP)IBA 10/2008
1	InterferonsIBA 10/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2008
1	Prednisolone (Predate)FDA LinkGeneric 10/2008
1	C-Reactive ProteinIBA 10/2008
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 10/2008
1	fibrinmonomerIBA 10/2008
1	fibrin fragment D (D-dimer)IBA 10/2008

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2020 - 04/2011
7	Therapeutics 04/2018 - 04/2008
2	Adjuvant Chemotherapy 01/2017 - 12/2014
1	Immunotherapy 01/2022
1	Chemoradiotherapy 01/2020
1	Palliative Care (Palliative Therapy) 04/2018
1	Colectomy 11/2015
1	Lymph Node Excision (Lymph Node Dissection) 11/2015
1	Ligation 11/2015
1	Oral Administration 02/2014
1	Drug Tapering 02/2014
1	Glycemic Control 02/2014
1	Molecular Targeted Therapy 04/2011